Tag: Stem cells
Stanford CVI Biobank: A Growing Library of Human iPSC Lines for Cardiovascular Research
Banking has been around for more than 4,000 years and involves saving and lending resources for personal and communal benefits. Biobanking, on the other hand, is a modern application of this historical concept, specifically in the field of medical...
Lineage Cell Therapeutics Issued US Patent For Antigen Presenting Dendritic Cell Production System
Lineage Cell Therapeutics, Inc., a clinical-stage
biotechnology company developing novel cell therapies for unmet medical needs, has
announced that the United States Patent and Trademark Office (USPTO) has issued
U.S. Patent No. 10,344,262, for a system for production of antigen presenting
dendritic cells...
Americord Registry Launches Amniotic Membrane Biobanking, New Product
Americord Registry has launched its newest stem cell banking
product, Placental Tissue 2.0™. Americord was one of the first family cord
blood banks to store placental tissue and now offers this exciting product,
which stores live amniotic membrane (AM), a first for...
Be The Match® And Gift Of Life® Marrow Registry To Open Blood Stem Cell...
Be The Match® and Gift of Life® Marrow Registry, intend to open, in
late July, the first registry-operated blood stem cell collection facility in
Boca Raton, Florida. The Gift of Life - Be The Match Collection Center brings
to life a new...
TreeFrog Therapeutics Raises $7.8M To Develop C-Stem™ 3D Stem Cell Culture In Multiple Indications
TreeFrog Therapeutics, an expert stem cell company, has
raised €7.1M (USD $7.8M) in a Series A funding round. The proceeds will be used
to transition the company’s C-Stem™ technology to cGMP standards by 2021 and to
develop proprietary and collaborative cell therapy...
FDA Grants RMAT To ExCellThera’s Cell Expansion Technology
ExCellThera Inc., an advanced clinical stage biotechnology
company delivering molecules and bioengineering solutions to expand stem and
immune cells for therapeutic use, has announced that the U.S. Food and Drug
Administration (FDA) has granted regenerative medicine advanced therapy (RMAT)
designation to its lead...
BrainStorm Cell Therapeutics Contracts Cleveland Clinic For Multiple Sclerosis Clinical Trial Site
BrainStorm Cell Therapeutics Inc., has announced that the Cleveland Clinic is the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in...
Houston Stem Cells Clinic Inc Opened By China Infrastructure Construction Corp
China Infrastructure Construction Corp., (CHNC) has announced that it has opened Houston Stem Cells Clinic Inc., as a wholly owned subsidiary of CHNC. According to Reuters, CHNC has an office in Wheat Ridge, Colorado, USA. Houston Stem Cell Clinic Inc....
Cellect Prepared For US Clinical Trial
Cellect Biotechnology Ltd. has announced a collaboration with Washington University in St. Louis, Missouri, USA, in a U.S. Phase I/II study aimed at determining the safety and tolerability of using ApoGraft™ for bone marrow transplantations. Founded in 2011, located in...
Cellect Biotechnology Completes Scale-Up Of Clinical Grade FasL; Enabling Stem Cell Therapy
Cellect Biotechnology Ltd. has announced that it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier. Founded in 2011, located in Tel Aviv, Isreal, Cellect Biotechnology has developed a breakthrough technology for...
